CAPTRUST Financial Advisors
AGIO icon

CAPTRUST Financial Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-196
Closed -$4K – 2101
2022
Q2 		$4K Buy
196
+30
+18% +$678 ﹤0.01% 4156
2022
Q1 		$5K Buy
166
+158
+1,975% +$4.83K ﹤0.01% 4130
2021
Q4 		$0 Sell
8
-24
-75% -$966 ﹤0.01% 4751
2021
Q3 		$1K Sell
32
-571
-95% -$27.6K ﹤0.01% 4393
2021
Q2 		$33K Sell
603
-1,125
-65% -$62.9K ﹤0.01% 2767
2021
Q1 		$89K Buy
1,728
+347
+25% +$17.2K ﹤0.01% 2039
2020
Q4 		$60K Sell
1,381
-20
-1% -$791 ﹤0.01% 1740
2020
Q3 		$49K Buy
1,401
+57
+4% +$2.5K ﹤0.01% 1633
2020
Q2 		$75K Buy
+1,344
New +$62.2K ﹤0.01% 1460

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAPTRUST Financial Advisors's AGIO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Agios Pharmaceuticals (AGIO) in Q3 2022, closing a stake of 196 shares — an estimated $4K sold.

CAPTRUST Financial Advisors first reported a position in AGIO in Q2 2020 and held it in 9 quarters. The position peaked at $89K in Q1 2021. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Agios Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 196 Agios Pharmaceuticals shares in Q3 2022, an estimated $4K.
  • CAPTRUST Financial Advisors first reported a position in Agios Pharmaceuticals in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's Agios Pharmaceuticals position peaked at $89K in Q1 2021.
  • 168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.